EUVIMEDEUVIMED entdecken
Crossref

An N ‐glycopeptide MS/MS data analysis workflow leveraging two complementary glycoproteomic software tools for more confident identification and assignments

Chu-Wei Kuo iD, Ning-En Chang, Pei-Yu Yu, Tzu-Jing Yang, Shang-Te Danny Hsu, Kay-Hooi Khoo iD

PROTEOMICS · 2023

DOI: 10.1002/pmic.202300143 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, 2023. Verfasst von Chu-Wei Kuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan. Hauptthemen laut MEDLINE: Glycopeptides, Software, Tandem Mass Spectrometry, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Academia Sinica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complete coverage of all N ‐glycosylation sites on the SARS‐CoV2 spike protein would require the use of multiple proteases in addition to trypsin. Subsequent identification of the resulting glycopeptides by searching against database often introduces assignment errors due to similar mass differences between different permutations of amino acids and glycosyl residues. By manually interpreting the individual MS 2 spectra, we report here the common sources of errors in assignment, especially those introduced by the use of chymotrypsin. We show that by applying a stringent threshold of acceptance, erroneous assignment by the commonly used Byonic software can be controlled within 15%, which can be reduced further if only those also confidently identified by a different search engine, pGlyco3, were considered. A representative site‐specific N ‐glycosylation pattern could be constructed based on quantifying only the overlapping subset of N ‐glycopeptides identified at higher confidence. Applying the two complimentary glycoproteomic software in a concerted data analysis workflow, we found and confirmed that glycosylation at several sites of an unstable Omicron spike protein differed significantly from those of the stable trimeric product of the parental D614G variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycopeptidesSoftwareTandem Mass SpectrometryProteomicsSpike Glycoprotein, CoronavirusGlycosylationSARS-CoV-2WorkflowHumansCOVID-19

Stichwörter der Autor:innen

SARS-CoV-2mass spectrometrysite-specific glycosylationspike glycoprotein

Substanzen

GlycopeptidesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
  • Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan.
  • International Institute for Sustainability with Knotted Chiral Meta Matter, Hiroshima University, Higashihiroshima, Japan.

ORCID-Profile: Chu-Wei Kuo, Kay-Hooi Khoo

Förderung

  • Academia Sinica

Zitieren

APA

Kuo, C. W., Chang, N. E., Yu, P. Y., Yang, T. J., Hsu, S. D., & Khoo, K. H. (2023). An N ‐glycopeptide MS/MS data analysis workflow leveraging two complementary glycoproteomic software tools for more confident identification and assignments. PROTEOMICS. https://doi.org/10.1002/pmic.202300143

Vancouver

Kuo CW, Chang NE, Yu PY, Yang TJ, Hsu SD, Khoo KH. An N ‐glycopeptide MS/MS data analysis workflow leveraging two complementary glycoproteomic software tools for more confident identification and assignments. PROTEOMICS. 2023. doi:10.1002/pmic.202300143

BibTeX
@article{Kuo2023,
  author = {Kuo, Chu-Wei and Chang, Ning-En and Yu, Pei-Yu and Yang, Tzu-Jing and Hsu, Shang-Te Danny and Khoo, Kay-Hooi},
  title = {An N ‐glycopeptide MS/MS data analysis workflow leveraging two complementary glycoproteomic software tools for more confident identification and assignments},
  journal = {PROTEOMICS},
  year = {2023},
  doi = {10.1002/pmic.202300143}
}
Kostenlos starten →